Ford Motor Company (F) reported declines in revenues and earnings for the second quarter of 2018 due to certain production disruption issues at a parts supplier as well as challenges in the China market. Total revenues declined 2.2% to $38.9 billion from the same period last year.
Net income dropped to $1.1 billion or $0.27 per diluted share from $2 billion or $0.51 per share in the prior-year period. Adjusted EPS was $0.27 in the quarter. The company’s quarterly results missed market expectations.
Revenues in the Automotive Segment dropped to $35.9 billion from the prior-year quarter. Business in North America remained strong, with F-Series sales topping 236,000 units in the second quarter. Although a fire briefly impacted production at one of its suppliers, measures were taken to restore operations quickly.
Ford had a challenging quarter in Asia Pacific and Europe. Due to this, the company lowered its adjusted EPS guidance for the full year of 2018 to a range of $1.30 to $1.50.
Ford is redesigning its business models by reallocating capital to high-return projects, restructuring, and strategic partnerships. These activities are expected to have potential EBIT charges of $11 billion, with cash-related effects of $7 billion, over the next 3-5 years.
On Tuesday, Ford announced the spinoff of its self-driving business into a separate company named Ford Autonomous Vehicles LLC. This decision was taken to grow its self-driving business faster and to take advantage of market opportunities. Ford will invest $4 billion in this company until 2023.
Ford’s disappointing quarterly results, combined with the guidance cut, sent shares down over 3% following the earnings release. Earlier in the day, Ford’s rival General Motors (GM) reported results with lower profit guidance for the year. The auto industry expects negative impacts from the tariff issues going on between the US and China.
Related: Ford Q1 earnings beats estimates, plans more savings
Related: Ford tops US carmakers in auto quality ranking
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
